Roche’s Seven-Minute Tecentriq Jab Wins First Ever Regulatory Approval

Tecentriq SC To Be Made Available Under Existing Commercial Deal

The National Health Service in England says it will be the first health system in the world to roll out a subcutaneously administered formulation of Tecentriq, after the UK MHRA became the first drug regulator to approve the product.

Subcutaneously administered Tecentriq will deliver convenient and faster care for patients • Source: Shutterstock

More from Approvals

More from Product Reviews